2 completed, 1 active not recruiting, 1 enrolling by invitation, 1 recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1 |
Follow Attralus, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome 124I-evuzamitide - Lumbar Spinal Stenosis, Carpal Tunnel Syndrome (CTS) | Phase 2 | Enrolling by invitation | University of Tennessee Graduate School of Medicine | 40 | 2025-05-22 | 2026-07-21 |
| A Study of AT-02 in Subjects With Systemic Amyloidosis. AT02 - Amyloidosis; Systemic | Phase 2 | Active not recruiting | Attralus, Inc. | 120 | 2023-09-21 | 2026-05-06 |
| Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis 124I-Evuzamitide - Amyloidosis, Transthyretin Amyloidosis | Phase 2 | Recruiting | Oregon Health and Science University | 150 | 2023-01-10 | 2026-04-13 |
| Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR I 124-Evuzamitide - Transthyretin Amyloidosis | Phase 2 | Completed | Columbia University | 10 | 2022-07-08 | 2025-07-18 |
| A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis 124I-AT-01 - Amyloidosis | Phase 2 | Completed | Attralus, Inc. | 33 | 2021-11-30 | 2025-09-04 |
Amyloidosis (3) · Amyloidosis, Hereditary, Transthyretin-Related (2) · Amyloid Neuropathies, Familial (1) · Carpal Tunnel Syndrome (1) · Immunoglobulin Light-chain Amyloidosis (1) · Spinal Stenosis (1)
United States (5)
Emily B. Martin, PhD (1) · Gregory M. Bell, MD (1) · Mathew Maurer, MD (1)